Apply Proteomic Approaches to Biomarker Discovery

Typical molecular biomarkers include proteins, genetic mutations, and aberrant methylation patterns. abnormal transcripts, miRNAs, and other biological molecules. Protein biomarkers are considered reliable indicators of the disease state and clinical outcome as they are the endpoints of biological processes. Remarkable innovations in proteomic technologies in the last few years have greatly accelerated the process of biomarker discovery.